TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients

Tatsuo Matsuda, Eisaku Miyauchi, Yu Wen Hsu, Satoshi Nagayama, Kazuma Kiyotani, Makda Zewde, Jae Hyun Park, Taigo Kato, Makiko Harada, Shimpei Matsui, Masashi Ueno, Kazumasa Fukuda, Nobuaki Suzuki, Shoichi Hazama, Hiroaki Nagano, Hiroya Takeuchi, Wickii T. Vigneswaran, Yuko Kitagawa, Yusuke Nakamura

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Tumor draining lymph nodes (TDLNs) are located in the routes of lymphatic drainage from a primary tumor and have the highest risk of metastasis in various types of solid tumors. TDLNs are also considered as a tissue to activate the antitumor immunity, where antigen-specific effector T cells are generated. However, T cell receptor (TCR) repertoires in TDLNs have not been well characterized. We collected 23 colorectal cancer tumors with 203 lymph nodes with/without metastatic cancer cells (67 were metastasis-positive and the remaining 136 were metastasis-negative) and performed TCR sequencing. Metastasis-positive TDLNs showed a significantly lower TCR diversity and shared TCR clonotypes more frequently with primary tumor tissues compared to metastasis-negative TDLNs. Principal component analysis indicated that TDLNs with metastasis showed similar TCR repertoires. These findings suggest that cancer-reactive T cell clones could be enriched in the metastasis-positive TDLNs.

Original languageEnglish
Article numbere1588085
Issue number6
Publication statusPublished - 2019 Jun 3


  • T cell receptor
  • colorectal cancer
  • immunogenomics
  • immunotherapy
  • lymph node

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology


Dive into the research topics of 'TCR sequencing analysis of cancer tissues and tumor draining lymph nodes in colorectal cancer patients'. Together they form a unique fingerprint.

Cite this